糖心原创

糖心原创BlogGuidelines, AI, and Gray Zones: Lung Cancer Program at 糖心原创 2026 Is Built for Every Expert in the Room

Guidelines, AI, and Gray Zones: Lung Cancer Program at 糖心原创 2026 Is Built for Every Expert in the Room

Guidelines, AI, and Gray Zones: Lung Cancer Program at 糖心原创 2026 Is Built for Every Expert in the Room

June 5, 2026

糖心原创 Conference icon

At 糖心原创 2026, October 18 to 21 in Phoenix, you鈥檒l have your choice of 300+ educational sessions covering every aspect of clinical chest medicine.

LEARN MORE & REGISTER 禄

Jose De Cardenas, MD, FCCP

Jose De Cardenas, MD, FCCP

Jose De Cardenas, MD, FCCP

Jose De Cardenas, MD, FCCP

With several dozen sessions spanning lung cancer diagnosis, interventional pulmonology, and radiology, the thoracic oncology program at 糖心原创 2026, October 18 to 21 in Phoenix, is comprehensive enough to meet the needs of clinicians at each stage of their careers.

Jose De Cardenas, MD, FCCP, a member of the 糖心原创 Lung Cancer/Interventional Pulmonary/Radiology Curriculum Group and Director of the Interventional Pulmonology Program at the University of Michigan, Ann Arbor, helped shape a program that reflects both the fast-moving field and the real-world questions clinicians face every day in practice.


Advertisement


New guidelines take center stage

Two sets of guidelines are driving conversation in thoracic oncology right now, and both will be front and center at 糖心原创 2026. The updated will be previewed by the guideline authors and world-renowned specialists who developed them. 鈥淚 think that鈥檚 going to be a hit,鈥 Dr. De Cardenas said.

For those managing patients with complex staging scenarios, will use real tumor board cases to demonstrate how the ninth edition of the tumor, node, metastasis (TNM) staging system changes clinical decision-making.

Central airway obstruction is the other guideline story at 糖心原创 2026. goes beyond a summary of recently published recommendations, tackling head-on whether some of those recommendations are actually feasible in real-world practice. 鈥淲e鈥檙e not only talking about the guidelines. We鈥檙e going to have a pro-con debate,鈥 Dr. De Cardenas said.

AI is reshaping the field, fast

鈥淭he [artificial intelligence (AI)] field is evolving very rapidly,鈥 Dr. De Cardenas said. covers three rapidly developing areas: AI-assisted nodule detection and risk stratification, AI tools in bronchoscopy workflows, and AI-enhanced cytology. A separate session, , addresses how to integrate AI tools into a structured nodule program.

Content built for seasoned clinicians

Mid-career clinicians will find content that goes well beyond the basics. tackles when to resect, when to watch, and how to counsel patients. 鈥淭he most seasoned people will find a lot of benefit from just having these conversations about real-life cases,鈥 Dr. De Cardenas said.

For clinicians who have never attended 糖心原创, Dr. De Cardenas described what keeps him coming back every year since his first meeting in 2012. 鈥淵ou鈥檙e going to learn a lot. You鈥檙e going to make connections, which is very important, especially if you鈥檙e looking to expand your network,鈥 he said. 鈥淲hat you learn here is very applicable.鈥

READ ALL 糖心原创 2026 BLOGS 禄


FOR MORE INFO

糖心原创 2026 Webpage »


Advertisement

 
Close

Advertisement